These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7652961)
21. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease. Haffner SM Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961 [No Abstract] [Full Text] [Related]
22. The 4S study: a critical review. Pauciullo P Pharmacol Res; 1997 Mar; 35(3):165-6. PubMed ID: 9229401 [No Abstract] [Full Text] [Related]
23. The clinical therapeutic implications of the Scandinavian Simvastatin Survival Study. Dujovne CA Am J Cardiol; 1997 May; 79(10):1387-8. PubMed ID: 9165163 [TBL] [Abstract][Full Text] [Related]
24. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies. Elam MB; Cushman W; Applegate WB; Heimberg M Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876 [No Abstract] [Full Text] [Related]
25. [Data on cholesterol level screening of patients with ischemic heart disease in the light of the Scandinavian Simvastatin Survival Study]. Márk L; Kondacs A; Hanyecz V; Simondán G Orv Hetil; 1997 Jun; 138(26):1679-82. PubMed ID: 9289681 [TBL] [Abstract][Full Text] [Related]
26. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet; 1995 May; 345(8960):1274-5. PubMed ID: 7746058 [TBL] [Abstract][Full Text] [Related]
27. Simvastatin in the secondary prevention of coronary heart disease. Assmann G Pharmacol Res; 1997 Mar; 35(3):161. PubMed ID: 9229399 [No Abstract] [Full Text] [Related]
28. Scandinavian simvastatin study (4S). Manzato E Lancet; 1994 Dec 24-31; 344(8939-8940):1767; author reply 1767-8. PubMed ID: 7997016 [No Abstract] [Full Text] [Related]
29. The 4S study and its pharmacoeconomic implications. Reckless JP Pharmacoeconomics; 1996 Feb; 9(2):101-5. PubMed ID: 10172696 [No Abstract] [Full Text] [Related]
30. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives. McKenna CJ; Sugrue DD Ir Med J; 1995; 88(6):191. PubMed ID: 8575912 [No Abstract] [Full Text] [Related]
31. The 4S study: a critical review. Crepaldi G Pharmacol Res; 1997 Mar; 35(3):163. PubMed ID: 9229400 [No Abstract] [Full Text] [Related]
32. Cholesterol hypothesis vindicated by simvastatin study. Why did it take so long? Beamish RE; Dhalla NS Can J Cardiol; 1995 Mar; 11(3):191-2. PubMed ID: 7889435 [No Abstract] [Full Text] [Related]
33. Scandinavian simvastatin study (4S). White HD Lancet; 1994 Dec 24-31; 344(8939-8940):1766; author reply 1767-8. PubMed ID: 7997014 [No Abstract] [Full Text] [Related]
35. [Ischemic heart disease: is it really time to change therapeutic routines?]. Löfmark R Lakartidningen; 1995 Jun; 92(23):2413; discussion 2414. PubMed ID: 7783509 [No Abstract] [Full Text] [Related]
36. Statins and coronary artery disease--it's the clinical endpoints that count. Jackson G Br J Clin Pract; 1997; 51(1):2-3. PubMed ID: 9158261 [No Abstract] [Full Text] [Related]
37. The statin trials: closing arguments in the case against cholesterol? Gaw A Scott Med J; 1996 Aug; 41(4):99-100. PubMed ID: 8873306 [No Abstract] [Full Text] [Related]
38. [Is treatment of hypercholesterolemia able to reduce total mortality?]. Forti N Arq Bras Cardiol; 1995 Feb; 64(2):101. PubMed ID: 7575152 [No Abstract] [Full Text] [Related]